Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2015 1
2016 1
2017 1
2018 1
2019 6
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Predictors of tuberculosis treatment success under the DOTS program in Namibia.
Kibuule D, Verbeeck RK, Nunurai R, Mavhunga F, Ene E, Godman B, Rennie TW. Kibuule D, et al. Among authors: Rennie TW. Expert Rev Respir Med. 2018 Nov;12(11):979-987. doi: 10.1080/17476348.2018.1520637. Epub 2018 Oct 4. Expert Rev Respir Med. 2018. PMID: 30198358
Distribution of hepatitis B virus infection in Namibia.
Mhata P, Rennie TW, Small LF, Nyarang'o PM, Chagla Z, Hunter CJ. Mhata P, et al. Among authors: Rennie TW. S Afr Med J. 2017 Sep 22;107(10):882-886. doi: 10.7196/SAMJ.2017.v107i10.12171. S Afr Med J. 2017. PMID: 29022533 Free article.
The Lidose hard capsule formulation of fenofibrate is suprabioavailable compared to the nanoparticle tablet formulation under high-fat fed conditions.
Verbeeck RK, De Niet S, Lebrun S, Tremege M, Rennie TW, Coffiner M, Streel B, Cahay B. Verbeeck RK, et al. Among authors: Rennie TW. J Pharm Pharm Sci. 2015;18(1):61-7. doi: 10.18433/j3fg7g. J Pharm Pharm Sci. 2015. PMID: 25877442 Free article. Clinical Trial.
14 results
Jump to page
Feedback